• Please log in or register to access this feature.

Hepatobiliary Malignancies

You have full text access to this OnlineOpen article

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid–defined diet in C57BL/6 mice†

  1. Bo Wang1,
  2. Sarmila Majumder1,2,
  3. Gerard Nuovo2,3,
  4. Huban Kutay1,
  5. Stefano Volinia2,4,
  6. Tushar Patel2,5,
  7. Thomas D. Schmittgen2,6,
  8. Carlo Croce2,4,
  9. Kalpana Ghoshal1,2,‡,*,
  10. Samson T. Jacob1,2,‡,*

Article first published online: 29 MAY 2009

DOI: 10.1002/hep.23100

Issue

Hepatology

Hepatology

Volume 50, Issue 4, pages 1152–1161, October 2009

Additional Information

How to Cite

Wang, B., Majumder, S., Nuovo, G., Kutay, H., Volinia, S., Patel, T., Schmittgen, T. D., Croce, C., Ghoshal, K. and Jacob, S. T. (2009), Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid–defined diet in C57BL/6 mice. Hepatology, 50: 1152–1161. doi: 10.1002/hep.23100

Author Information

  1. 1

    Department of Molecular and Cellular Biochemistry, Ohio State University, Columbus, OH

  2. 2

    Comprehensive Cancer Center, Ohio State University, Columbus, OH

  3. 3

    Department of Pathology, Ohio State University, Columbus, OH

  4. 4

    Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, OH

  5. 5

    Department of Gastroenterology and Hepatology, Ohio State University, Columbus, OH

  6. 6

    Department of Pharmacy and Ohio State University, Columbus, OH

  1. ‡

    fax: 614-688-5600

*420 West 12th Avenue, Columbus, OH 43210

  1. †

    Potential conflict of interest: Nothing to report.

  2. ‡

    fax: 614-688-5600

Publication History

  1. Issue published online: 28 SEP 2009
  2. Article first published online: 29 MAY 2009
  3. Accepted manuscript online: 29 MAY 2009 12:00AM EST
  4. Manuscript Accepted: 17 MAY 2009
  5. Manuscript Received: 20 MAR 2009

Funded by

  • National Institutes of Health. Grant Numbers: CA086978, CA101956

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (1713K)

References

  • 1
    Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell 2004; 5: 215–219.
  • 2
    El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557–2576.
  • 3
    Yeh MM, Brunt EM. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 2007; 128: 837–847.
  • 4
    Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008; 134: 1682–1698.
  • 5
    Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 2008; 132: 9–14.
  • 6
    Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Mol Cell 2007; 26: 611–623.
  • 7
    Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 2008; 9: 219–230.
  • 8
    Croce CM. Oncogenes and cancer. N Engl J Med 2008; 358: 502–511.
  • 9
    Braconi C, Patel T. MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors. HEPATOLOGY 2008; 47: 1807–1809.
  • 10
    Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103: 2257–2261.
  • 11
    Denda A, Kitayama W, Kishida H, Murata N, Tsutsumi M, Tsujiuchi T, et al. Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, L-amino acid-defined diet. Jpn J Cancer Res 2002; 93: 125–132.
  • 12
    Nakae D. Endogenous liver carcinogenesis in the rat. Pathol Int 1999; 49: 1028–1042.
  • 13
    Liu CG, Calin GA, Volinia S, Croce CM. MicroRNA expression profiling using microarrays. Nat Protoc 2008; 3: 563–578.
  • 14
    Gorski K, Carneiro M, Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 1986; 47: 767–776.
  • 15
    Ghoshal K, Majumder S, Zhu Q, Hunzeker J, Datta J, Shah M, et al. Influenza virus infection induces metallothionein gene expression in the mouse liver and lung by overlapping but distinct molecular mechanisms. Mol Cell Biol 2001; 21: 8301–8317.
  • 16
    Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, et al. Downregulation of microRNA-1 (miR-1) in lung cancer: suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis bymiR-1. J Biol Chem 2008; 283: 33394–33405.
  • 17
    Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008; 68: 5049–5058.
  • 18
    Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. HEPATOLOGY 2008; 48: 1810–1820.
  • 19
    O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007; 104: 1604–1609.
  • 20
    Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647–658.
  • 21
    Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006; 99: 671–678.
  • 22
    Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res 2008; 36: 6608–6619.
  • 23
    Tomizawa M, Watanabe K, Saisho H, Nakagawara A, Tagawa M. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker. Anticancer Res 2003; 23: 351–354.
  • 24
    O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008; 205: 585–594.
  • 25
    Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 2006; 103: 7024–7029.
  • 26
    Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008; 27: 5651–5661.
  • 27
    Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 2005; 438: 685–689.
View Full Article with Supporting Information (HTML) Get PDF (1713K)